FROGGER'S HIDEOUT

[OCKHAM'S RAZOR]

GOBK .0199;

GOBK
http://globalinkworld.com/our-business
http://www.otcmarkets.com/stock/GOBK/profile
Globalink (GOBK) OWNS and CONTROLS over 20% of the WORLD'S SUPPLY of Gingko leaves, a crucial key raw material used in multiple pharmaceutical drug preparations ranging from Alzheimer's disease, Lyme disease, chemotherapy, depression, asthma, bronchitis, glaucoma, chronic fatigue syndrome, schizophrenia and heart disease.

Already 2 large global companies have supply and distribution partnerships, one being NASDAQ traded The Carlyle Group (CG) who through it's 100% owned subsidiary NBTY has revenues of over 3 BILLION dollars. Long term supply contracts are forecast to be forthcoming with ALL major BIG PHARMAS who rely on the raw material.

Insiders own almost 50% of GOBK- INSIDERS KNOW BEST
*Very limited number of shares only 45M O/S

A tiny float of 5M (which means that this stock could rise very quickly as investors compete for shares)
*Globalink, Ltd. (GOBK) first harvest of 60 tons of gingko leaves has already been pre-sold, such is the the demand for this pharmaceutical raw material. The company is at the early stages of phenomenal growth.

In recent SEC filings, Globalink (GOBK) is expanding and developing a gingko plantation that comprises approximately 1,553 acres, capable of producing up to 5,600 tons of dried gingko leaves per year making it one of the largest independent producers of gingko leaves in China. At current market prices, that's more than $300 million worth of gingko leaves.

Globalink (GOBK), utilizing modern scientific and technical procedures to control the entire growing process has attracted attention from pharmaceutical companies, health supplement manufacturers, and industry experts. Many companies have visited the plantation and have expressed interest in partnerships.

EXPECTING LARGE REVENUES
Looking at monster revenues Globalink (GOBK) also has had the foresight -They started it's own biotech company which it recently incorporated named Globalink (Zhejiang) Bio-Technology Co which is engaged in the research and development, cultivation, extraction, and application of gingko trees and other economic plants.

FUTURE CATALYSTS:
*Yearly Revenues projected to be over $300 MILLION within 5 years.

*Look for BIG PHARMA partnerships coming, uplisting and massive percentage rise in it's stock price.

http://globalinkworld.com/equinox/resources/resources/pdfs/News%20-%20revenue%20expecation%20-25May2016.pdf

http://globalinkworld.com/our-business
http://www.otcmarkets.com/stock/GOBK/profile